Table 2 Clinicopathological factors and their relationship to the expression of different proteins, assessed in AC cases
From: Prognostic significance of CD44s expression in resected non-small cell lung cancer
Characteristics | CD44s (n = 77) | COX-2 (n = 82) | ||
|---|---|---|---|---|
| Â | Low(%) | High(%) | Low(%) | High(%) |
Tumor differentiation | Â | Â | Â | Â |
   Well, | 7(33.3) | 14(66.7) | 7(31.8) | 15(68.2) |
   Moderately, poorly | 29(51.8) | 27(48.2) | 9(15.0) | 51(85.0) |
p-value | Â | 0.117 | Â | 0.085 |
Tumor size | Â | Â | Â | Â |
   < 3 cm | 12(42.9) | 16(57.1) | 1(3.4) | 28(96.6) |
   ≥ 3 cm | 24(50.0) | 24(50.0) | 14(26.9) | 38(73.1) |
p-value | Â | 0.547 | Â | 0.009 |
Lymph node metastasis | Â | Â | Â | Â |
   N0-1 | 33(53.2) | 29(46.8) | 14(20.9) | 539(79.1) |
   N2-3 | 3(20.0) | 12(80.0) | 2(13.3) | 13(86.7) |
p-value | Â | 0.021 | Â | 0.397 |
Stage | Â | Â | Â | Â |
   I | 20(48.8) | 21(51.2) | 10(23.3) | 33(76.7) |
   II | 8(53.3) | 7(46.7) | 3(16.7) | 15(83.3) |
   III | 8(38.1) | 13(61.9) | 3(14.3) | 18(85.7) |
p-value | Â | 0.616 | Â | 0.373 |
Lymphatic invasion | Â | Â | Â | Â |
   Negative | 19(42.2) | 26(57.8) | 11(23.4) | 36(76.6) |
   Positive | 16(53.3) | 14(46.7) | 5(15.2) | 28(84.8) |
p-value | Â | 0.345 | Â | 0.364 |